RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

Details for Australian Patent Application No. 2005201389 (hide)

International Classifications

Event Publications

14 April 2005 Complete Application Filed

Priority application(s): 10/824,036 14.04.04 US; 10/783,128 20.02.04 US; 10/923,536 20.08.04 US; 10/826,966 16.04.04 US

18 August 2005 Section 223 Application Allowed

Sirna Therapeutics, Inc. The time in which to claim the convention priority date has been extended to 20 Apr 2005. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

8 September 2005 Application Open to Public Inspection

Published as AU-A-2005201389

29 September 2005 Amendment Made

The nature of the amendment is: Add priority details PCT/US04/13456 US 30 April 2004 and PCT/US05/04270 US 9 February 2005

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.